Story perspectives
Study Links Ozempic to Increased Hair Loss Risk
3/26/2025
32 2
1 of 1
Story summary
- A recent study from the University of British Columbia reveals a potential link between semaglutide, found in Ozempic and Wegovy, and increased hair loss risk, particularly among women. Analyzing data from nearly 3,300 patients, researchers suggest that the rapid weight loss associated with the drug, rather than the medication itself, may be the culprit. Further investigation is essential to validate these results.
